Rhumbline Advisers CAN FITE BIOPHARMA LTD-ADR Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025
Number of Shares
57,582
Previous 38,268 50.47%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
N/A
19,314 Added 50.47%
57,582 $0
Q1 2025

Apr 08, 2025
BUY
N/A
11,388 Added 42.37%
38,268 $0
Q4 2024

May 29, 2025
SELL
N/A
-11,388 Reduced 29.76%
26,880 $0
Q4 2024

Jan 30, 2025
BUY
N/A
9,935 Added 58.63%
26,880 $0
Q3 2024

Nov 12, 2024
BUY
N/A
1,547 Added 10.05%
16,945 $0
Q2 2024

Aug 01, 2024
SELL
N/A
-3,084 Reduced 16.69%
15,398 $0
Q4 2023

Feb 08, 2024
BUY
N/A
560 Added 3.12%
18,482 $0
Q3 2023

Nov 09, 2023
BUY
N/A
820 Added 4.79%
17,922 $0
Q2 2023

Aug 08, 2023
BUY
N/A
17,102 New
17,102 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email